Co-Diagnostics News - August 2026

Co-Diagnostics second quarter 2026 revenue of $0.17M beat estimates as FDA submission was filed
CODX

Co-Diagnostics second quarter 2026 revenue of $0.17M beat estimates as FDA submission was filed

Co-Diagnostics reported second quarter 2026 revenue of $0.17 million, outperforming the $0.13 million consensus estimate. The company’s net loss narrowed to...
CODX

Co-Diagnostics, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026

Analysts expect Co-Diagnostics, Inc. to report a Q2 2026 consensus revenue of approximately $0.13 million and an EPS loss of $3.00, while the stock currently...